Skip to main content

Latest SEC Filings — Page 153

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Saga Communications Terminates Credit Facility After Covenant Breach; Q2 Revenue Falls 6.5%
Form 10-QSGA · Form 10-Q · 2026-08-14
Beasley 10-Q Flags Going Concern Doubt and $8M Asset Sale
ProForm 10-QBBGI · Form 10-Q · 2026-08-14
Cue Biopharma Q2 2026: $153M Net Loss, $17.4M Cash, CUE-221 IND Submitted
ProForm 8-KCUE · Form 8-K · 2026-08-14
Permianville Royalty Trust Q2 Distributable Income Jumps 298% to $1.12M on Haynesville Gas Surge
Form 10-QPVL · Form 10-Q · 2026-08-14
Smart Powerr Corp. Loses Six Directors and Officers in a Single Day
ProForm 8-KCREG · Form 8-K · 2026-08-14
ICZOOM Shareholders Approve 1-for-5 Reverse Split and Authorize Further Consolidation
Form 6-KIZM · Form 6-K · 2026-08-14
WORK Medical Announces $2.1M Private Placement at $1.00/Share
Form 6-KWOK · Form 6-K · 2026-08-14
ESG Inc. Flags Going Concern Doubt, Debt Default, and Material Weakness in Q2 10-Q
ProForm 10-QESGH · Form 10-Q · 2026-08-14
SKK Holdings Prices $3.4M Direct Offering at $4.46, Accepts Stablecoins
Form 424B5SKK · Form 424B5 · 2026-08-14
Big Digital Energy Posts Q2 Loss and Reiterates Going Concern Warning Amid Heavy Debt
ProForm 10-QBGDE · Form 10-Q · 2026-08-14
Nauticus Robotics Registers 181M Shares for $250M Equity Facility at $1.38 Assumed Price
Form 424B3KITT · Form 424B3 · 2026-08-14
WinVest Seeks Stockholder Approval to Extend SPAC Deadline to March 2027
Form PRE 14AWINV · Form PRE 14A · 2026-08-14
Anfield Energy's Q2 Loss Widens, US$6.86M Offering Closes, and US$10M Arbitration Claim Emerges
Form 6-KAEC · Form 6-K · 2026-08-14
Raphael Pharmaceutical Discloses $1,000 Cash Balance and Going Concern Warning
ProForm 10-QRAPH · Form 10-Q · 2026-08-14
Going Concern Doubt and Control Weaknesses Surface in Alternus Clean Energy's Q2 10-Q
ProForm 10-QACLEW · Form 10-Q · 2026-08-14
Powerdyne Q2: Revenue Down 25%, Toxic Debt Conversions, CEO Death, Going Concern
ProForm 10-QPWDY · Form 10-Q · 2026-08-14
60 Degrees Pharmaceuticals Reports Q2 Loss, Cash Runway Through Early October
ProForm 10-QSXTP · Form 10-Q · 2026-08-14
Balance Labs Flags Going Concern, Defaulted Notes, and Control Weaknesses
ProForm 10-QBLNC · Form 10-Q · 2026-08-14
PrimeEnergy Q2 Net Income Doubles to $6.5M on Higher Oil Prices
Form 10-QPNRG · Form 10-Q · 2026-08-14
HCW Biologics Q2 Loss Widens to $5.2M; Going Concern Warning Issued
ProForm 10-QHCWB · Form 10-Q · 2026-08-14
Global Innovative Platforms Reports First Quarterly Revenue and Strengthens Cash Position
Form 10-QGIPL · Form 10-Q · 2026-08-14
Heartflow Affiliate Files to Sell $6.2M in Shares
Form 144HTFL · Form 144 · 2026-08-14
Digi Power X Q2 2026: First AI Revenue, $1.1B Backlog, but $14.4M Net Loss
ProForm 10-QDGXX · Form 10-Q · 2026-08-14
Ocean Thermal Energy Corp 10-Q: Going Concern, 800M Share Authorization, and CEO's OCEES Deal
ProForm 10-QCPWR · Form 10-Q · 2026-08-14
Exicure Q2 10-Q: Cash Drops to $1.7M, Nasdaq Equity Deficiency, Going Concern Doubt
ProForm 10-QXCUR · Form 10-Q · 2026-08-14
Car-Mart Seeks 1M Share Increase to Equity Plan Amid Distress
Form DEF 14ACRMT · Form DEF 14A · 2026-08-14
Braskem 2Q26 Earnings Call: Segment EBITDA Surge to US$1.04B, But Going Concern Doubt Persists
Form 6-KBAK · Form 6-K · 2026-08-14
HCW Biologics Reports Q2 Loss, Going Concern Warning, and Clinical Progress
ProForm 8-KHCWB · Form 8-K · 2026-08-14
Protagenic Therapeutics 10-K: Going Concern, Nasdaq Delisting, and $7.3M Unwind Gain
ProForm 10-KPTIX · Form 10-K · 2026-08-14
Q2 Revenue Falls 21.5% as Material Weaknesses Persist
ProForm 10-QIVFH · Form 10-Q · 2026-08-14